Par-4 Downregulation Promotes Breast Cancer Recurrence by Preventing Multinucleation following Targeted Therapy

Cancer Cell

Volumn 24, Issue 1, 2013, Pages 30-44

  Alvarez, James V ^a,b   Pan, Tien chi ^a,b   Ruth, Jason ^a,b   Feng, Yi ^a,b   Zhou, Alice ^a,b   Pant, Dhruv ^a,b   Grimley, Joshua S ^c   Wandless, Thomas J ^c   DeMichele, Angela ^b   Chodosh, Lewis A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; LAPATINIB; MYOSIN LIGHT CHAIN 2; PACLITAXEL; PHOSPHOTRANSFERASE; PROTEINASE ACTIVATED RECEPTOR 4; UNCLASSIFIED DRUG; ZIP KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CELL CYCLE ARREST; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOKINESIS; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULARLY TARGETED THERAPY; MOUSE; MULTINUCLEAR CELL; NONHUMAN; ONCOGENE NEU; PAR 4 GENE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; TREATMENT RESPONSE; TUMOR CELL; TUMOR REGRESSION; TUMOR SUPPRESSOR GENE; UPREGULATION;

EID: 84880033826     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2013.05.007     Document Type: Article

References (32)

1. Andreassen P.R., Lohez O.D., Lacroix F.B., Margolis R.L. Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1. Mol. Biol. Cell 2001, 12:1315-1328.
2. Banaszynski L.A., Chen L.C., Maynard-Smith L.A., Ooi A.G., Wandless T.J. A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules. Cell 2006, 126:995-1004.
3. Bednarz-Knoll N., Alix-Panabières C., Pantel K. Clinical relevance and biology of circulating tumor cells. Breast Cancer Res. 2011, 13:228.
4. Boosen M., Vetterkind S., Kubicek J., Scheidtmann K.H., Illenberger S., Preuss U. Par-4 is an essential downstream target of DAP-like kinase (Dlk) in Dlk/Par-4-mediated apoptosis. Mol. Biol. Cell 2009, 20:4010-4020.
5. Boxer R.B., Jang J.W., Sintasath L., Chodosh L.A. Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation. Cancer Cell 2004, 6:577-586.
6. Castedo M., Coquelle A., Vivet S., Vitale I., Kauffmann A., Dessen P., Pequignot M.O., Casares N., Valent A., Mouhamad S., et al. Apoptosis regulation in tetraploid cancer cells. EMBO J. 2006, 25:2584-2595.
7. D'Cruz C.M., Gunther E.J., Boxer R.B., Hartman J.L., Sintasath L., Moody S.E., Cox J.D., Ha S.I., Belka G.K., Golant A., et al. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat. Med. 2001, 7:235-239.
8. Diaz-Meco M.T., Abu-Baker S. The Par-4/PTEN connection in tumor suppression. Cell Cycle 2009, 8:2518-2522.
9. Díaz-Meco M.T., Municio M.M., Frutos S., Sanchez P., Lozano J., Sanz L., Moscat J. The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C. Cell 1996, 86:777-786.
10. Esserman L.J., Berry D.A., Cheang M.C., Yau C., Perou C.M., Carey L., Demichele A., Gray J.W., Conway-Dorsey K., Lenburg M.E., et al. Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657). Breast Cancer Res Treat. 2012, 132:1049-1062.
11. Fujiwara T., Bandi M., Nitta M., Ivanova E.V., Bronson R.T., Pellman D. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 2005, 437:1043-1047.
12. Ganem N.J., Pellman D. Limiting the proliferation of polyploid cells. Cell 2007, 131:437-440.
13. Ganem N.J., Storchova Z., Pellman D. Tetraploidy, aneuploidy and cancer. Curr. Opin. Genet. Dev. 2007, 17:157-162.
14. Gunther E.J., Moody S.E., Belka G.K., Hahn K.T., Innocent N., Dugan K.D., Cardiff R.D., Chodosh L.A. Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis. Genes Dev. 2003, 17:488-501.
15. Gurumurthy S., Goswami A., Vasudevan K.M., Rangnekar V.M. Phosphorylation of Par-4 by protein kinase A is critical for apoptosis. Mol. Cell. Biol. 2005, 25:1146-1161.
16. Mansilla S., Priebe W., Portugal J. Mitotic catastrophe results in cell death by caspase-dependent and caspase-independent mechanisms. Cell Cycle 2006, 5:53-60.
17. Margolis R.L., Lohez O.D., Andreassen P.R. G1 tetraploidy checkpoint and the suppression of tumorigenesis. J.Cell. Biochem. 2003, 88:673-683.
18. Matsumura F. Regulation of myosin II during cytokinesis in higher eukaryotes. Trends Cell Biol. 2005, 15:371-377.
19. Méndez-López L.F., Zapata-Benavides P., Zavala-Pompa A., Aguado-Barrera M.E., Pacheco-Calleros J., Rodríguez-Padilla C., Cerda-Flores R.M., Cortés-Gutiérrez E.I., Dávila-Rodríguez M.I. Immunohistochemical analysis of prostate apoptosis response-4 (Par-4) in Mexican women with breast cancer: a preliminary study. Arch. Med. Res. 2010, 41:261-268.
20. Moody S.E., Sarkisian C.J., Hahn K.T., Gunther E.J., Pickup S., Dugan K.D., Innocent N., Cardiff R.D., Schnall M.D., Chodosh L.A. Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. Cancer Cell 2002, 2:451-461.
21. Moody S.E., Perez D., Pan T.C., Sarkisian C.J., Portocarrero C.P., Sterner C.J., Notorfrancesco K.L., Cardiff R.D., Chodosh L.A. The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 2005, 8:197-209.
22. Nagai M.A., Gerhard R., Salaorni S., Fregnani J.H., Nonogaki S., Netto M.M., Soares F.A. Down-regulation of the candidate tumor suppressor gene PAR-4 is associated with poor prognosis in breast cancer. Int. J. Oncol. 2010, 37:41-49.
23. Page G., Kögel D., Rangnekar V., Scheidtmann K.H. Interaction partners of Dlk/ZIP kinase: co-expression of Dlk/ZIP kinase and Par-4 results in cytoplasmic retention and apoptosis. Oncogene 1999, 18:7265-7273.
24. Piekny A.J., Mains P.E. Rho-binding kinase (LET-502) and myosin phosphatase (MEL-11) regulate cytokinesis in the early Caenorhabditis elegans embryo. J.Cell Sci. 2002, 115:2271-2282.
25. Ranganathan P., Rangnekar V.M. Regulation of cancer cell survival by Par-4. Ann. N Y Acad. Sci. 2005, 1059:76-85.
26. Saphner T., Tormey D.C., Gray R. Annual hazard rates of recurrence for breast cancer after primary therapy. J.Clin. Oncol. 1996, 14:2738-2746.
27. Sells S.F., Wood D.P., Joshi-Barve S.S., Muthukumar S., Jacob R.J., Crist S.A., Humphreys S., Rangnekar V.M. Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells. Cell Growth Differ. 1994, 5:457-466.
28. Sells S.F., Han S.S., Muthukkumar S., Maddiwar N., Johnstone R., Boghaert E., Gillis D., Liu G., Nair P., Monnig S., et al. Expression and function of the leucine zipper protein Par-4 in apoptosis. Mol. Cell. Biol. 1997, 17:3823-3832.
29. Symmans W.F., Peintinger F., Hatzis C., Rajan R., Kuerer H., Valero V., Assad L., Poniecka A., Hennessy B., Green M., et al. Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J.Clin. Oncol. 2007, 25:4414-4422.
30. Vetterkind S., Morgan K.G. The pro-apoptotic protein Par-4 facilitates vascular contractility by cytoskeletal targeting of ZIPK. J.Cell. Mol. Med. 2009, 13:887-895.
31. Vetterkind S., Illenberger S., Kubicek J., Boosen M., Appel S., Naim H.Y., Scheidtmann K.H., Preuss U. Binding of Par-4 to the actin cytoskeleton is essential for Par-4/Dlk-mediated apoptosis. Exp. Cell Res. 2005, 305:392-408.
32. Yamashiro S., Yamakita Y., Totsukawa G., Goto H., Kaibuchi K., Ito M., Hartshorne D.J., Matsumura F. Myosin phosphatase-targeting subunit 1 regulates mitosis by antagonizing polo-like kinase 1. Dev. Cell 2008, 14:787-797.